Making proteins for research or therapies often starts with cell-line development. In many applications, genetic engineering is used to optimize a cell line for producing high levels of the intended ...
Microbial systems offer distinct advantages in protein expression, saving costs and time, and offering well-characterized host genetics and ease of scale-up. 2 However, challenges remain in process ...
The host cell system is a critical determinant of recombinant protein quality and yield, with direct influence on protein folding and post-translational modification factors that shape the ...
Pharming uses living organisms as bioreactors for cheaper, sustainable drug production, but requires navigating complex IP ...
The launch of AlbuFree™ DX underscores Dyadic’s strategy to prioritize recombinant protein products that have clear commercial pathways and are supported by well-established end markets. Under the ...
The pre-Series A funding round was co-led by existing backer WaterBridge Ventures and Japanese VC firm Enrission India Capital Founded in 2019, Loopworm manufactures high-protein animal feeds from ...
The EVERY Company Further Expands its IP Estate with European Union Patent for Recombinant Ovalbumin
SAN FRANCISCO--(BUSINESS WIRE)--The EVERY Company (“EVERY”), a leader in crafting highly functional protein ingredients, has been granted yet another seminal patent for its recombinant Ovalbumin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results